Protein carbamylation is a hallmark of aging

Proceedings of the National Academy of Sciences of the United States of America

Volumn 113, Issue 5, 2016, Pages 1191-1196

  Gorisse, Laëtitia ^a   Pietrement, Christine ^a,b   Vuiblet, Vincent ^a,c   Schmelzer, Christian E H ^d   Köhler, Martin ^d   Duca, Laurent ^a   Debelle, Laurent ^a   Fornès, Paul ^c   Jaisson, Stéphane ^a,e   Gillery, Philippe ^a,e  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b AMERICAN MEMORIAL HOSPITAL   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e HÔPITAL MAISON BLANCHE   (France)

Author keywords

Carbamylation; Longevity; Nonenzymatic posttranslational modifications; Skin; Tissue aging

Indexed keywords

COLLAGEN TYPE 1; ELASTIN; HOMOCITRULLINE; MATRIX PROTEIN; PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARBAMOYLATION; CASE REPORT; CELL AGING; CONTROLLED STUDY; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIFE EXPECTANCY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; YOUNG ADULT; AGING; AMINO ACID SEQUENCE; ANIMAL; C57BL MOUSE; METABOLISM; MOLECULAR GENETICS;

AGING; AMINO ACID SEQUENCE; ANIMALS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS;

EID: 84957310306     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1517096113     Document Type: Article

References (53)

1. Grimes A, Chandra SBC (2009) Significance of cellular senescence in aging and cancer. Cancer Res Treat 41 (4): 187-195.
2. Brack C, Lithgow G, Osiewacz H, Toussaint O (2000) EMBO WORKSHOP REPORT: Molecular and cellular gerontology Serpiano, Switzerland, September 18-22, 1999. EMBO J 19 (9): 1929-1934.
3. Haigis MC, Yankner BA (2010) The aging stress response. Mol Cell 40 (2): 333-344.
4. Gillery P, Jaisson S (2013) Usefulness of non-enzymatic post-translational modification derived products (PTMDPs) as biomarkers of chronic diseases. J Proteomics 92: 228-238.
5. Li JJ, Surini M, Catsicas S, Kawashima E, Bouras C (1995) Age-dependent accumulation of advanced glycosylation end products in human neurons. Neurobiol Aging 16 (1): 69-76.
6. Albon J, Karwatowski WS, Avery N, Easty DL, Duance VC (1995) Changes in the collagenous matrix of the aging human lamina cribrosa. Br J Ophthalmol 79 (4): 368-375.
7. Basta G, Schmidt AM, De Caterina R (2004) Advanced glycation end products and vascular inflammation: Implications for accelerated atherosclerosis in diabetes. Cardiovasc Res 63 (4): 582-592.
8. Schinzel R, Münch G, Heidland A, Sebekova K (2001) Advanced glycation end products in end-stage renal disease and their removal. Nephron 87 (4): 295-303.
9. Odetti P, et al. (2005) Advanced glycation end products and bone loss during aging. Ann N Y Acad Sci 1043: 710-717.
10. Haus JM, Carrithers JA, Trappe SW, Trappe TA (2007) Collagen, cross-linking, and advanced glycation end products in aging human skeletal muscle. J Appl Physiol (1985) 103 (6): 2068-2076.
11. Verzijl N, et al. (2000) Effect of collagen turnover on the accumulation of advanced glycation end products. J Biol Chem 275 (50): 39027-39031.
12. Yamagishi S, Fukami K, Matsui T (2015) Evaluation of tissue accumulation levels of advanced glycation end products by skin autofluorescence: A novel marker of vascular complications in high-risk patients for cardiovascular disease. Int J Cardiol 185: 263-268.
13. Grossin N, et al. (2015) Dietary CML-enriched protein induces functional arterial aging in a RAGE-dependent manner in mice. Mol Nutr Food Res 59 (5): 927-938.
14. Gillery P, Jaisson S (2014) Post-translational modification derived products (PTMDPs): Toxins in chronic diseases? Clin Chem Lab Med 52 (1): 33-38.
15. Kraus LM, Kraus AP, Jr (2001) Carbamoylation of amino acids and proteins in uremia. Kidney Int Suppl 78: S102-S107.
16. Jaisson S, Gorisse L, Pietrement C, Gillery P (2012) Quantification of plasma homocitrulline using hydrophilic interaction liquid chromatography (HILIC) coupled to tandem mass spectrometry. Anal Bioanal Chem 402 (4): 1635-1641.
17. Wang Z, et al. (2007) Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 13 (10): 1176-1184.
18. Sirpal S (2009) Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease. Clin Sci (Lond) 116 (9): 681-695.
19. Roberts JM, et al. (2011) Isocyanic acid in the atmosphere and its possible link to smoke-related health effects. Proc Natl Acad Sci USA 108 (22): 8966-8971.
20. Stark GR, Stein WH, Moore S (1960) Reactions of the cyanate present in aqueous urea with amino acids and proteins. J Biol Chem 235 (11): 3177-3181.
21. Nicholson DH, Harkness DR, Benson WE, Peterson CM (1976) Cyanate-induced cataracts in patients with sickle-cell hemoglobinopathies. Arch Ophthalmol 94 (6): 927-930.
22. Jaisson S, et al. (2015) Increased serum homocitrulline concentrations are associated with the severity of coronary artery disease. Clin Chem Lab Med 53 (1): 103-110.
23. Apostolov EO, Basnakian AG, Ok E, Shah SV (2012) Carbamylated low-density lipoprotein: Nontraditional risk factor for cardiovascular events in patients with chronic kidney disease. J Ren Nutr 22 (1): 134-138.
24. Shi J, et al. (2014) Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies. Autoimmun Rev 13 (3): 225-230.
25. Berg AH, et al. (2013) Carbamylation of serum albumin as a risk factor for mortality in patients with kidney failure. Sci Transl Med 5 (175): 175ra29.
26. Koeth RA, et al. (2013) Protein carbamylation predicts mortality in ESRD. J Am Soc Nephrol 24 (5): 853-861.
27. Kalim S, et al. (2013) Carbamylation of serum albumin and erythropoietin resistance in end stage kidney disease. Clin J Am Soc Nephrol 8 (11): 1927-1934.
28. Pietrement C, Gorisse L, Jaisson S, Gillery P (2013) Chronic increase of urea leads to carbamylated proteins accumulation in tissues in a mouse model of CKD. PLoS One 8 (12): E82506.
29. Asci G, et al. (2008) Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells. Nephrology (Carlton) 13 (6): 480-486.
30. Shiu SW, et al. (2014) Carbamylation of LDL and its relationship with myeloperoxidase in type 2 diabetes mellitus. Clin Sci (Lond) 126 (2): 175-181.
31. Oimomi M, et al. (1987) Carbamylation of insulin and its biological activity. Nephron 46 (1): 63-66.
32. Park KD, Mun KC, Chang EJ, Park SB, Kim HC (2004) Inhibition of erythropoietin activity by cyanate. Scand J Urol Nephrol 38 (1): 69-72.
33. Koro C, et al. (2014) Carbamylation of immunoglobulin abrogates activation of the classical complement pathway. Eur J Immunol 44 (11): 3403-3412.
34. Sell DR, et al. (1996) Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci USA 93 (1): 485-490.
35. Sell DR, Kleinman NR, Monnier VM (2000) Longitudinal determination of skin collagen glycation and glycoxidation rates predicts early death in C57BL/6NNIA mice. FASEB J 14 (1): 145-156.
36. Chondrogianni N, et al. (2014) Protein damage, repair and proteolysis. Mol Aspects Med 35: 1-71.
37. Singh VP, Bali A, Singh N, Jaggi AS (2014) Advanced glycation end products and diabetic complications. Korean J Physiol Pharmacol 18 (1): 1-14.
38. Chuah YK, Basir R, Talib H, Tie TH, Nordin N (2013) Receptor for advanced glycation end products and its involvement in inflammatory diseases. Int J Inflamm 2013: 403460.
39. Simm A (2013) Protein glycation during aging and in cardiovascular disease. J Proteomics 92: 248-259.
40. Castellani RJ, et al. (2001) Active glycation in neurofibrillary pathology of Alzheimer disease: N (epsilon) -(carboxymethyl) lysine and hexitol-lysine. Free Radic Biol Med 31 (2): 175-180.
41. Verzijl N, et al. (2000) Age-related accumulation of Maillard reaction products in human articular cartilage collagen. Biochem J 350 (Pt 2): 381-387.
42. Jaisson S, et al. (2006) Impact of carbamylation on type I collagen conformational structure and its ability to activate human polymorphonuclear neutrophils. Chem Biol 13 (2): 149-159.
43. Jaisson S, et al. (2007) Carbamylation differentially alters type I collagen sensitivity to various collagenases. Matrix Biol 26 (3): 190-196.
44. Mun KC, Golper TA (2000) Impaired biological activity of erythropoietin by cyanate carbamylation. Blood Purif 18 (1): 13-17.
45. Kraus LM, Traxinger R, Kraus AP (2004) Uremia and insulin resistance: N-carbamoyl-asparagine decreases insulin-sensitive glucose uptake in rat adipocytes. Kidney Int 65 (3): 881-887.
46. Yoshinaga E, et al. (2012) N (e) -(carboxymethyl) lysine modification of elastin alters its biological properties: Implications for the accumulation of abnormal elastic fibers in actinic elastosis. J Invest Dermatol 132 (2): 315-323.
47. Pickering AM, Lehr M, Miller RA (2015) Lifespan of mice and primates correlates with immunoproteasome expression. J Clin Invest 125 (5): 2059-2068.
48. Pickering AM, et al. (2010) The immunoproteasome, the 20S proteasome and the PA28aβ proteasome regulator are oxidative-stress-adaptive proteolytic complexes. Biochem J 432 (3): 585-594.
49. Jaisson S, Gillery P (2014) Impaired proteostasis: Role in the pathogenesis of diabetes mellitus. Diabetologia 57 (8): 1517-1527.
50. Shang F, Taylor A (2012) Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: Implications in the pathogenesis of agerelated macular degeneration. Mol Aspects Med 33 (4): 446-466.
51. Gkogkolou P, Böhm M (2012) Advanced glycation end products: Key players in skin aging? Dermatoendocrinol 4 (3): 259-270.
52. Vlassara H, Palace MR (2002) Diabetes and advanced glycation endproducts. J Intern Med 251 (2): 87-101.
53. Schmelzer CEH, Jung MC, Wohlrab J, Neubert RHH, Heinz A (2012) Does human leukocyte elastase degrade intact skin elastin? FEBS J 279 (22): 4191-4200.